Spacetalk Ltd (ASX:SPA) Announces Q3 and H1 FY25 Financial Results
Spacetalk Ltd (ASX:SPA) announces a 26% revenue growth in Q3FY25 and outlines plans to achieve $20-25M ARR by 2026.
Worley Limited (ASX:WOR) Reaffirms FY25 Outlook at Investor Day
Worley Limited (ASX:WOR) reaffirms its FY25 financial outlook and outlines growth strategy at Investor Day 2025.
Brazilian Rare Earths Limited (ASX:BRE) Secures Strategic Partnership with SENAI CIMATEC
Brazilian Rare Earths Limited (ASX:BRE) secures a strategic partnership with SENAI CIMATEC to develop a pilot plant and laboratory for rare earth beneficiation.
Zoono Group Limited (ASX:ZNO) Secures Exclusive UK Packaging Agreement
Zoono Group Limited (ASX:ZNO) signs an exclusive UK packaging agreement to enhance food shelf-life extension solutions.
Chimeric Therapeutics (ASX:CHM) Announces $6.6 Million Placement to Advance Clinical Trials
Chimeric Therapeutics (ASX:CHM) announces a $6.6 million placement to fund key clinical trials in its cell therapy pipeline.
Monash IVF Group (ASX:MVF) Updates FY25 Profit Guidance
Monash IVF Group (ASX:MVF) revises FY25 Underlying NPAT guidance to $27.5m, reflecting softer market conditions.
Noxopharm Limited (ASX:NOX) Raises $2.5 Million from Nyrada Share Sale
Noxopharm Limited (ASX:NOX) raised $2.5 million through a share sale to fund upcoming clinical trials and R&D initiatives.
OFX Group Limited (ASX:OFX) Announces FY25 Results and Accelerated Platform Roll-Out
OFX Group Limited (ASX:OFX) reports resilient FY25 results and accelerates its New Client Platform roll-out to drive growth.
Brisbane Broncos Limited (ASX:BBL) Announces 2024 Financial Results
Brisbane Broncos Limited (ASX:BBL) announces 2024 financial results, highlighting revenue growth, increased membership, and a final dividend declaration.
Kogan.com Ltd (ASX:KGN) Announces May 2025 Business Update
Kogan.com Ltd (ASX:KGN) reports strong sales growth and profitability driven by increased marketing investment and customer growth.